338 related articles for article (PubMed ID: 37276955)
1. Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pancreatic cancer treatment.
Luo Y; Li C; Zhang Y; Liu P; Chen H; Zhao Z; Wang Y; Zhou Z; Song H; Su B; Li C; Li X; Zhang T; You H; Wu Y; Tian Z; Zhang S; Guo Y; Fan H; Chen Q; Jiang C; Sun T
Acta Biomater; 2023 Sep; 167():387-400. PubMed ID: 37276955
[TBL] [Abstract][Full Text] [Related]
2. Penetrating Micelle for Reversing Immunosuppression and Drug Resistance in Pancreatic Cancer Treatment.
Chen Q; Wang Q; Wang Y; Chu Y; Luo Y; You H; Su B; Li C; Guo Q; Sun T; Jiang C
Small; 2022 May; 18(18):e2107712. PubMed ID: 35285149
[TBL] [Abstract][Full Text] [Related]
3. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming.
Zhao T; Zhang R; He Q; Zhou H; Song X; Gong T; Zhang Z
Acta Biomater; 2022 Jun; 145():122-134. PubMed ID: 35381402
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in targeted drug delivery for the treatment of pancreatic ductal adenocarcinoma.
Song H; Jiang C
Expert Opin Drug Deliv; 2022 Mar; 19(3):281-301. PubMed ID: 35220832
[TBL] [Abstract][Full Text] [Related]
5. A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors.
Zhang F; Hu Q; Li B; Huang Y; Wang M; Shao S; Tang H; Yao Z; Ping Y; Liang T
J Control Release; 2023 Feb; 354():835-850. PubMed ID: 36627026
[TBL] [Abstract][Full Text] [Related]
6. Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma.
Xiao H; Li X; Li B; Zhong Y; Qin J; Wang Y; Han S; Ren J; Shuai X
Acta Biomater; 2023 Apr; 161():265-274. PubMed ID: 36893956
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival.
Urbanova M; Cihova M; Buocikova V; Slopovsky J; Dubovan P; Pindak D; Tomas M; García-Bermejo L; Rodríguez-Garrote M; Earl J; Kohl Y; Kataki A; Dusinska M; Sainz B; Smolkova B; Gabelova A
Biomed Pharmacother; 2023 Sep; 165():115179. PubMed ID: 37481927
[TBL] [Abstract][Full Text] [Related]
8. An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancer.
Guo J; Wang S; Gao Q
Front Immunol; 2023; 14():1258538. PubMed ID: 37771596
[TBL] [Abstract][Full Text] [Related]
9. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
[TBL] [Abstract][Full Text] [Related]
10. Codelivery Nanosystem Targeting the Deep Microenvironment of Pancreatic Cancer.
Chen X; Zhou W; Liang C; Shi S; Yu X; Chen Q; Sun T; Lu Y; Zhang Y; Guo Q; Li C; Zhang Y; Jiang C
Nano Lett; 2019 Jun; 19(6):3527-3534. PubMed ID: 31058513
[TBL] [Abstract][Full Text] [Related]
11. A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote the immunotherapy of pancreatic cancer.
Wang R; Hong K; Zhang Q; Cao J; Huang T; Xiao Z; Wang Y; Shuai X
Acta Biomater; 2023 Oct; 169():451-463. PubMed ID: 37572982
[TBL] [Abstract][Full Text] [Related]
12. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB
Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Tumor Microenvironment.
Wang K; He H
Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
[TBL] [Abstract][Full Text] [Related]
14. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.
Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K
Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719
[No Abstract] [Full Text] [Related]
15. Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer.
Chen H; Guo Q; Chu Y; Li C; Zhang Y; Liu P; Zhao Z; Wang Y; Luo Y; Zhou Z; Zhang T; Song H; Li X; Li C; Su B; You H; Sun T; Jiang C
Biomaterials; 2022 Aug; 287():121599. PubMed ID: 35777332
[TBL] [Abstract][Full Text] [Related]
16. High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment.
Sadozai H; Acharjee A; Kayani HZ; Gruber T; Gorczynski RM; Burke B
Front Immunol; 2024; 15():1360629. PubMed ID: 38510243
[TBL] [Abstract][Full Text] [Related]
17. An Integrated Tumor Microenvironment Responsive Polymeric Micelle for Smart Drug Delivery and Effective Drug Release.
Zhang N; Liu W; Dong Z; Yin Y; Luo J; Lu T; Tang W; Wang Y; Han Y
Bioconjug Chem; 2021 Sep; 32(9):2083-2094. PubMed ID: 34472841
[TBL] [Abstract][Full Text] [Related]
18. Synergistic autophagy blockade and VDR signaling activation enhance stellate cell reprogramming in pancreatic ductal adenocarcinoma.
Kong W; Liu Z; Sun M; Liu H; Kong C; Ma J; Wang R; Qian F
Cancer Lett; 2022 Jul; 539():215718. PubMed ID: 35526650
[TBL] [Abstract][Full Text] [Related]
19. Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for promoting therapeutic efficiency.
Chen D; Zhu X; Tao W; Kong Y; Huag Y; Zhang Y; Liu R; Jiang L; Tang Y; Yu H; Hao Q; Yang X; Zou H; Chen J; Lu Y; Zhang H; Li W
J Control Release; 2020 Aug; 324():545-559. PubMed ID: 32504777
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment.
Zhu YH; Zheng JH; Jia QY; Duan ZH; Yao HF; Yang J; Sun YW; Jiang SH; Liu DJ; Huo YM
Cell Oncol (Dordr); 2023 Feb; 46(1):17-48. PubMed ID: 36367669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]